eGenesis
Wes Westlin has held various leadership roles in research and development in the pharmaceutical industry for over three decades. Wes served as an Executive Vice President at eGenesis, Inc., and Vice President at Celgene, Avila Therapeutics, and Nimbus Therapeutics. Wes was also a Board of Director at Exo Therapeutics. Throughout their career, Wes has focused on preclinical research and early development, contributing significantly to the advancement of new therapies in oncology and immunoinflammatory diseases.
Wes Westlin earned a Doctor of Philosophy (PhD) in Pharmacology from New York Medical College.
eGenesis
2 followers
eGenesis is revolutionizing the field of transplantation with an unparalleled, multiplexed gene editing platform for the development of human-compatible organs, tissues and cells.